Previous studies have indicated that the IHC markers of BC patients show varying degrees of alterations after NAC.[38,39] In the present study, among the 91 non-pCR patients, the conversion rates of ER and HER2 were 4.4% and 6.6%, respectively. This evidence concerns the gene ERBB2 and breast cancer.